Key facts
- NeuroReserve’s last known valuation is $8.8M (Apr 2025).
- It has raised $2.3M across 3 recorded rounds; the latest was Seed Round ($691K) in Jan 2025.
- Notable investors include Battle Born Venture, Reno Seed Advisors.
- NeuroReserve has filed 6 Form Ds with the SEC since 2019, most recently Apr 2025 ($691K sold to 5 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for NeuroReserve
Funding rounds
3 roundsAbout NeuroReserve
Manufacturer of brain supplement products intended to provide nutrition to the brain. The company's products are made with protective nutritional compounds by conducting a long-term dietary study, enabling consumers to protect their lifelong brain health.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Las Vegas, NV, United States
- Founded
- 2017
- Employees
- 5
- Website
- neuroreserve.com/
- Ownership
- Privately Held (backing)
NeuroReserve doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuroReserve shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuroReserve in its N-PORT filings yet. We sweep new filings monthly.